脑部放疗，上午比下午敏感许多！
3 [+ a4 @4 S; {
9 o6 ]. s8 |8 q" \% b4 u& J2 E' w2 Z: P2 _
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.2 ]" _! u" r2 s: a6 j6 d0 G
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
, H5 @/ V" b+ ?& v* g3 BRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
3 x( z% W# L7 }4 x9 y3 e7 `" ZSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.' Z% x' _( i X- M& M
& A: ~% c* k# w& j3 FAbstract: A2 u0 c- B: W1 `- j# Y
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
9 T9 N3 N# B+ h0 d# r
; }1 @' D" S0 b6 T" jMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.3 W! v: u) f9 U8 F! w4 O
: H9 e! z, [. ~3 l' J
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).- `0 o: M& b% X" i! x( X4 `5 g
& a l9 y6 [; b( Y
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
+ a: p4 F B( I; \5 K; ]/ t% }: \1 F, s; c# ?$ P I& d! W5 c
|
# K' l6 o4 R- `4 W4 ]4 Y1 i* a
显身卡
